Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase III clinical trial update for Benvitimod Cream in mild to moderate atopic dermatitis is reported but status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD) [Phase 2]
Phase 2 trial update of subcutaneously administered CM310 vs placebo in moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating the efficacy and safety of oral difelikefalin (CR845) for moderate to severe pruritus in subjects with atopic der…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating FB825 in adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial update evaluating efficacy, pharmacokinetics, and safety of FB825 in adults with atopic dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating Upadacitinib in combination with topical corticosteroids for adolescents and adults with moderate-to-severe atopi…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) [Phase 3]
A Phase 3 trial (Measure Up 2) evaluating Upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis has completed and…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) [Phase 3]
Phase 3 study measuring upadacitinib in adolescents and adults with moderate to severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study [Phase 2]
Phase 2 trial update for Medihoney Derma Cream in children with mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis [Phase 2]
Phase 2 study on tezepelumab for atopic dermatitis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 1, Phase 2]
A clinical trial update for CM326 in moderate-to-severe atopic dermatitis (Phase 1/Phase 2) with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. [Phase 4]
Phase 4 clinical trial update exploring dupilumab for atopic dermatitis monitored with noninvasive imaging.
-
FDA approval · 2022-02-18FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)
FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a…
-
FDA approval · 2022-02-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Quagen Pharmaceuticals LLC)
FDA approved the original application for a generic clobetasol propionate topical product by Quagen Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) [Phase 3]
Phase 3 trial assessing effectiveness and safety of desloratadine syrup in children with atopic dermatitis and dermatitis conditions; study …
-
EMA withdrawal · 2022-02-08EMA Withdrawn: Staquis (Crisaborole) — Pfizer Europe MA EEIG
The EMA has withdrawn Staquis (crisaborole) from the market in Europe.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) [Phase 3]
Phase 3 trial updates evaluate upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis, with results posted in Febr…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial comparing safety and efficacy of Upadacitinib versus Dupilumab in adults with moderate to severe atopic dermatitis has complet…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) [Phase 2]
Phase II study of HY209 gel for atopic dermatitis completed.
-
FDA approval · 2022-01-14FDA Approved: CIBINQO — Original Application (U.S. Pharmaceuticals)
FDA approved CIBINQO (abrocitinib) through an original New Drug Application from U.S. Pharmaceuticals. It is indicated for the treatment of …
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis [Phase 1, Phase 2]
A clinical trial update investigating safety and efficacy of multiple doses of FURESTEM-AD Inj. for moderate to severe atopic dermatitis in …
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD [Phase 4]
Phase 4 trial update for crisaborole ointment 2% versus vehicle and topical corticosteroids/immune modulators in mild-moderate atopic dermat…
-
FDA approval · 2021-12-27FDA Approved: ADBRY — Original Application (LEO Pharma Inc.)
FDA approved ADBRY (tralokinumab-ldrm) through an original Biologics License Application filed by LEO Pharma Inc.
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier [Phase 2]
Phase 2 trial update on a novel moisturiser for atopic dermatitis evaluating skin barrier effects; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis [Phase 3]
Phase 3 trial update for ruxolitinib cream in adolescents and adults with atopic dermatitis; study completed with posted results.